Inventor · disambiguated record
Kevin Schaab
Also filed as: SCHAAB KEVIN · SCHAAB KEVIN M · SCHAAB KEVIN MURRAY
5 granted patents·4 pending applications·1 citations·filing 2008–2022
61Inventor score
Files withINTERCEPT PHARMACEUTICALS INC4AMIRA PHARMACEUTICALS INC1DENOVX LLC1HUTCHINSON JOHN HOWARD1REWOLINSKI MELISSA VIRGINIA1
Top patents by PatentIndex Score
9 records- 0164US8697730B25-lipoxygenase activating protein (FLAP) inhibitorREWOLINSKI MELISSA VIRGINIA·Filed 2008·Granted Apr 15, 2014·1 cites·15 claims
- 0262US2023057232A1Isotopically labeled bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0358US11472831B2Isotopically labeled bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Oct 18, 2022·0 cites·15 claims
- 0452US9193664B2Directed nucleation and crystal growth from solution using surface energy modified amorphous materialsDENOVX LLC·Filed 2014·Granted Nov 24, 2015·0 cites·20 claims
- 0551US2011311613A1Topical formulations of flap inhibitors for the treatment of dermatological conditionsHUTCHINSON JOHN HOWARD·Filed 2009·Application pending·0 cites
- 0642US8772495B25-lipoxygenase-activating protein inhibitorSCHAAB KEVIN MURRAY·Filed 2009·Granted Jul 8, 2014·0 cites·7 claims
- 0739US2010173313A1Biomarkers of inflammationAMIRA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 0838US2020024299A1Crystalline forms of a bile acid derivativeINTERCEPT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0930US11072631B2Methods and intermediates for the preparation bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Jul 27, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Schaab files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →